Company Filing History:
Years Active: 2001-2008
Title: Innovations of Motonori Aoshima in Hemostatic Solutions
Introduction
Motonori Aoshima is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical technology, particularly in the development of hemostatic agents. With a total of five patents to his name, Aoshima's work focuses on innovative solutions for treating wounds and promoting healing.
Latest Patents
One of Aoshima's latest patents is centered around hemostatic soluble cellulose fibers containing coagulating proteins for treating wounds. This novel soluble trauma-healing and hemostatic cellulose fiber is designed to absorb and dissolve hemorrhaging trauma sites upon application. It promotes the hemostatic action of blood platelets, fibrin, and enhances cell adhesion to the trauma site. The production process involves treating natural or regenerated cellulose fibers with an aqueous sodium hydroxide solution, followed by carboxymethylation using monochloroacetic acid. This process ensures that the degree of partial substitution of the glucose units in the cellulose molecule is maintained at a specific level. Additionally, coagulation proteins such as fibrinogen, thrombin, and coagulation factor XIII are incorporated through surface application or chemical bonding.
Career Highlights
Aoshima's career is marked by his dedication to advancing medical technology. His innovative approaches have led to the development of effective hemostatic agents that are crucial in emergency medical situations. His work not only addresses immediate medical needs but also contributes to the broader field of wound care and healing.
Collaborations
Aoshima has collaborated with notable colleagues, including Gilbu Soe and Koichi Takada. These partnerships have fostered a collaborative environment that enhances the research and development of new medical solutions.
Conclusion
Motonori Aoshima's contributions to the field of hemostatic solutions exemplify the impact of innovation in medical technology. His patents reflect a commitment to improving patient care and advancing the science of wound healing.